UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increased serum resistin but not G-CSF levels are associated in the pathophysiology of major depressive disorder: Findings from a case-control study

PloS one, 2022-02, Vol.17 (2), p.e0264404-e0264404

2022

Volltextzugriff (PDF)

Higher serum nerve growth factor levels are associated with major depressive disorder pathophysiology: a case–control study

Journal of international medical research, 2023-04, Vol.51 (4), p.3000605231166222-3000605231166222

2023

Volltextzugriff (PDF)

Altered serum interleukin-7 and interleukin-10 are associated with drug-free major depressive disorder

Therapeutic advances in psychopharmacology, 2020, Vol.10, p.2045125320916655-2045125320916655

2020

Volltextzugriff (PDF)

Elevated Serum IL-2 Levels are Associated With Major Depressive Disorder: A Case-Control Study

Clinical pathology (Thousand Oaks, Ventura County, Calif.), 2023-01, Vol.16, p.2632010X231180797-2632010X231180797

2023

Volltextzugriff (PDF)

Serum interferon-gamma level is associated with drug-naïve major depressive disorder

SAGE open medicine, 2020, Vol.8, p.2050312120974169-2050312120974169

2020

Volltextzugriff (PDF)

Evaluation of serum amino acids and non-enzymatic antioxidants in drug-naïve first-episode major depressive disorder

BMC psychiatry, 2020-06, Vol.20 (1), p.1-333, Article 333

2020

Volltextzugriff (PDF)

Altered serum adiponectin and interleukin-8 levels are associated in the pathophysiology of major depressive disorder: A case-control study

PloS one, 2022-11, Vol.17 (11), p.e0276619-e0276619

2022

Volltextzugriff (PDF)

Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: A case-control study

PloS one, 2023-07, Vol.18 (7), p.e0288159-e0288159

2023

Volltextzugriff (PDF)

Evaluation of serum MIP-1β and MCP-2 levels in major depressive disorder: A case-control study

PloS one, 2024-06, Vol.19 (6), p.e0305734

2024

Volltextzugriff (PDF)

Association of granulocyte macrophage colony-stimulating factor and interleukin-17 levels with obsessive–compulsive disorder: a case–control study findings

Scientific reports, 2023-11, Vol.13 (1), p.18976-18976, Article 18976

2023

Volltextzugriff (PDF)

Monocyte chemoattractant protein-1 levels are associated with major depressive disorder

Journal of Basic and Clinical Physiology and Pharmacology, 2022-11, Vol.33 (6), p.735-741

2022

Volltextzugriff (PDF)

Altered IL-3 and lipocalin-2 levels are associated with the pathophysiology of major depressive disorder: a case-control study

BMC psychiatry, 2023-11, Vol.23 (1), p.830-830, Article 830

2023

Volltextzugriff (PDF)

Prevalence and associated factors for elevated fear and depressive symptoms among the private service holders in Bangladesh during the Covid‐19 pandemic: A cross‐sectional study

Health science reports, 2022-09, Vol.5 (5), p.e795-n/a

2022

Volltextzugriff (PDF)

Data set concerning the use of social networking sites and mental health problems among the young generation in Bangladesh

Data in brief, 2021-12, Vol.39, p.107593-107593, Article 107593

2021

Volltextzugriff (PDF)

Elevated Serum Macrophage Migration Inhibitory Factor Levels are Associated With Major Depressive Disorder

Clinical pathology (Thousand Oaks, Ventura County, Calif.), 2023-01, Vol.16, p.2632010X231220841-2632010X231220841

2023

Volltextzugriff (PDF)

Higher levels of serum IL-1β and TNF-α are associated with an increased probability of major depressive disorder

Psychiatry research, 2021-01, Vol.295, p.113568-113568, Article 113568

2021

Volltextzugriff (PDF)

Evaluation of serum MIP-1[beta] and MCP-2 levels in major depressive disorder: A case-control study

PloS one, 2024-06, Vol.19 (6), p.e0305734

2024

Volltextzugriff (PDF)

Serum insulin-like growth factor-1 and relaxin-3 are linked with major depressive disorder

Asian journal of psychiatry, 2020-10, Vol.53, p.102164-102164, Article 102164

2020

Volltextzugriff (PDF)

Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: A case-control study

PloS one, 2023-01, Vol.18 (7), p.e0288159

2023

Volltextzugriff (PDF)

Altered serum adiponectin and interleukin-8 levels are associated in the pathophysiology of major depressive disorder: A case-control study

PloS one, 2022-01, Vol.17 (11), p.e0276619

2022

Volltextzugriff (PDF)

Allium sativum L. Improves Visual Memory and Attention in Healthy Human Volunteers

Evidence-based complementary and alternative medicine, 2015-01, Vol.2015 (2015), p.1-8

2015

Volltextzugriff (PDF)

The Effect of Chronic Alprazolam Intake on Memory, Attention, and Psychomotor Performance in Healthy Human Male Volunteers

Behavioural neurology, 2016-01, Vol.2016 (2016), p.1-9

2016

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Increased serum resistin but not G-CSF levels are associated in the pathophysiology of major depressive disorder: Findings from a case-control study

Higher serum nerve growth factor levels are associated with major depressive disorder pathophysiology: a case–control study

Altered serum interleukin-7 and interleukin-10 are associated with drug-free major depressive disorder

Elevated Serum IL-2 Levels are Associated With Major Depressive Disorder: A Case-Control Study

Serum interferon-gamma level is associated with drug-naïve major depressive disorder

Evaluation of serum amino acids and non-enzymatic antioxidants in drug-naïve first-episode major depressive disorder

Altered serum adiponectin and interleukin-8 levels are associated in the pathophysiology of major depressive disorder: A case-control study

Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: A case-control study

Evaluation of serum MIP-1β and MCP-2 levels in major depressive disorder: A case-control study

Association of granulocyte macrophage colony-stimulating factor and interleukin-17 levels with obsessive–compulsive disorder: a case–control study findings

Monocyte chemoattractant protein-1 levels are associated with major depressive disorder

Altered IL-3 and lipocalin-2 levels are associated with the pathophysiology of major depressive disorder: a case-control study

Prevalence and associated factors for elevated fear and depressive symptoms among the private service holders in Bangladesh during the Covid‐19 pandemic: A cross‐sectional study

Data set concerning the use of social networking sites and mental health problems among the young generation in Bangladesh

Elevated Serum Macrophage Migration Inhibitory Factor Levels are Associated With Major Depressive Disorder

Higher levels of serum IL-1β and TNF-α are associated with an increased probability of major depressive disorder

Evaluation of serum MIP-1[beta] and MCP-2 levels in major depressive disorder: A case-control study

Serum insulin-like growth factor-1 and relaxin-3 are linked with major depressive disorder

Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: A case-control study

Altered serum adiponectin and interleukin-8 levels are associated in the pathophysiology of major depressive disorder: A case-control study

Allium sativum L. Improves Visual Memory and Attention in Healthy Human Volunteers

The Effect of Chronic Alprazolam Intake on Memory, Attention, and Psychomotor Performance in Healthy Human Male Volunteers

Suchergebnisse filtern